PYC Therapeutics $653M Equity Raising for Drugs
Perth-based biotech firm PYC Therapeutics announces a $653 million equity raising to fund the advancement of its innovative drug portfolio, targeting key therapeutic areas.
Category : Biotechnology
FDA fast-tracks Singular Health medical imaging software
Perth's Singular Health secures accelerated FDA clearance for its cloud-based 3DICOM MD Cloud, targeting US$16.5bn in healthcare inefficiencies. Read how this Australian innovation transforms medical imaging.
Biotech Soars on Real-World Stem Cell Therapy Results
NeuroScientific Biopharmaceuticals shares surge after its StemSmart stem cell therapy shows significant clinical response in patients with fistulising Crohn's disease, validating its $5.1m acquisition.
Funnel Web Spider Venom Drug Enters Human Trials
Queensland researchers begin human trials for IB409, a revolutionary drug derived from funnel web spider venom that could prevent cell death during heart attacks and strokes.
Singular Health files FDA application for 3DICOM Cloud
Perth-based Singular Health Group submits 510(k) to US FDA for its cloud-based 3D medical imaging platform. Approval could transform global healthcare access and slash duplicate scan costs.
Ex-Woodside CEO Peter Coleman leads PYC Therapeutics
Former Woodside Energy boss Peter Coleman takes helm at PYC Therapeutics following board crisis and managing director's brief resignation. Key leadership change aims to restore investor confidence.
Fourth Crohn's Patient Treated with Stem Cell Therapy
NeuroScientific Biopharmaceuticals has dosed a fourth patient with its StemSmart stem-cell therapy for fistulising Crohn's disease, marking a key step for the Australian biotech. Discover the potential of this game-changing treatment.
WA innovators score PM's top science honour for medical breakthrough
Two Western Australian researchers have claimed Australia's most prestigious science awards for developing revolutionary technology that could transform emergency medicine worldwide.
UOW's revolutionary device targets pancreatic cancer
University of Wollongong researchers develop groundbreaking implant technology that could transform pancreatic cancer treatment in Australian healthcare.
Page 1 of 1